FDA Approves Automated Insulin Delivery & Monitoring System For Children With Diabetes

On August 31, 2020, the U.S. Food and Drug Administration (FDA) approved the Medtronic plc MiniMed 770G System, an automated insulin delivery and monitoring system, for use by children between ages two and six diagnosed with type 1 diabetes. It is the first continuous glucose monitoring (CGM) and insulin delivery system for very young children. The device can automatically adjust insulin delivery based on CGM values for this population with little or no input from the users or their caregivers. Users still need to manually request insulin doses to counter carbohydrate consumption at mealtime. On September 1, 2020, the . . .